Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors — Neutral
CYTK GlobeNewsWire — November 17, 2025LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cytokinetics, Incorporated, (“Cytokinetics” or the "Company") (NASDAQ: CYTK) investors of a class action on behalf of investors that bought securities between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). Cytokinetics investors have until November 17, 2025 to file a lead plaintiff motion.
KBR Investors Have Opportunity to Lead KBR, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
KBR GlobeNewsWire — November 17, 2025LOS ANGELES, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against KBR, Inc. (“KBR” or “the Company”) (NYSE: KBR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 6, 2025 and June 19, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before November 18, 2025.
Novo Nordisk is now offering its anti-obesity drug for as low as $199 per month — Positive
NVO Invezz — November 17, 2025Novo Nordisk (NYSE: NVO) has announced sweeping price cuts for its blockbuster GLP-1 drugs, Wegovy and Ozempic, offering patients access to the lowest doses for just $199/month. New cash-paying patients will be able to access its anti-obesity treatments at that price for the first two months, the pharmaceutical behemoth confirmed in a press release today.
US oil, gas rig count slows despite record output, EIA says — Neutral
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP Reuters — November 17, 2025U.S. oil and natural gas drilling activity has continued to decline even as production reaches record highs, the U.S. Energy Information Administration (EIA) said on Monday.
Should You Join the CLS Bandwagon on Rising Earnings Estimates? — Positive
CLS Zacks Investment Research — November 17, 2025CLS' rising earnings estimates and accelerating AI-driven demand spotlight its expanding role in high-value tech infrastructure.
What Analyst Projections for Key Metrics Reveal About Valvoline (VVV) Q4 Earnings — Positive
VVV Zacks Investment Research — November 17, 2025Beyond analysts' top-and-bottom-line estimates for Valvoline (VVV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Ahead of Maximus (MMS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics — Neutral
MMS Zacks Investment Research — November 17, 2025Evaluate the expected performance of Maximus (MMS) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Investing in Onto Innovation (ONTO)? Don't Miss Assessing Its International Revenue Trends — Positive
ONTO Zacks Investment Research — November 17, 2025Evaluate Onto Innovation's (ONTO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Unveiling Veeva (VEEV) Q3 Outlook: Wall Street Estimates for Key Metrics — Positive
VEEV Zacks Investment Research — November 17, 2025Besides Wall Street's top-and-bottom-line estimates for Veeva (VEEV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2025.
Arbe Robotics Ltd. (ARBE) Q3 2025 Earnings Call Transcript — Neutral
ARBE Seeking Alpha — November 17, 2025Arbe Robotics Ltd. ( ARBE ) Q3 2025 Earnings Call November 17, 2025 8:30 AM EST Company Participants Jacob Marenko - Co-Founder, CEO & Director Karine Pinto-Flomenboim - Chief Financial Officer Conference Call Participants Kenny Green Sujeeva De Silva - ROTH Capital Partners, LLC, Research Division George Gianarikas - Canaccord Genuity Corp., Research Division Presentation Operator Good day, everyone, and welcome to the Arbe Robotics Third Quarter 2025 Results Conference Call.
Countdown to Gap (GAP) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS — Positive
GAP Zacks Investment Research — November 17, 2025Besides Wall Street's top-and-bottom-line estimates for Gap (GAP), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2025.
Full Truck Alliance Co. Ltd. (YMM) Q3 2025 Earnings Call Transcript — Neutral
YMM Seeking Alpha — November 17, 2025Full Truck Alliance Co. Ltd. ( YMM ) Q3 2025 Earnings Call November 17, 2025 7:00 AM EST Company Participants Mao Mao - Head of Investor Relations Hui Zhang - Founder, Chairman & CEO Chong Cai - Chief Financial Officer Conference Call Participants Ronald Keung - Goldman Sachs Group, Inc., Research Division Eddy Wang - Morgan Stanley, Research Division Brian Gong - Citigroup Inc., Research Division Yuan Liao - Citic Securities Co., Ltd.
International Markets and Rockwell Automation (ROK): A Deep Dive for Investors — Positive
ROK Zacks Investment Research — November 17, 2025Evaluate Rockwell Automation's (ROK) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Jaguar Health, Inc. (JAGX) Q3 2025 Earnings Call Prepared Remarks Transcript — Neutral
JAGX Seeking Alpha — November 17, 2025Jaguar Health, Inc. ( JAGX ) Q3 2025 Earnings Call November 17, 2025 8:30 AM EST Company Participants Lisa Conte - Founder, CEO, President & Director Carol Lizak - Chief Financial Officer Presentation Operator Greetings, and welcome to the Jaguar Health's Investor Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Bath & Body Works (BBWI) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates — Neutral
BBWI Zacks Investment Research — November 17, 2025Evaluate the expected performance of Bath & Body Works (BBWI) for the quarter ended October 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Sohu.com Limited (SOHU) Q3 2025 Earnings Call Transcript — Neutral
SOHU Seeking Alpha — November 17, 2025Sohu.com Limited ( SOHU ) Q3 2025 Earnings Call November 17, 2025 7:30 AM EST Company Participants Pu Huang - Investor Relations Officer - China Charles Zhang - Founder, Chairman & CEO Joanna Lv - Chief Financial Officer Conference Call Participants Thomas Chong - Jefferies LLC, Research Division Alicis a Yap - Citigroup Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by, and good evening. Thank you for joining Sohu's Third Quarter 2025 Earnings Conference Call.
Don't Overlook Cisco (CSCO) International Revenue Trends While Assessing the Stock — Neutral
CSCO Zacks Investment Research — November 17, 2025Explore Cisco's (CSCO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Unlocking Q4 Potential of Post Holdings (POST): Exploring Wall Street Estimates for Key Metrics — Neutral
POST Zacks Investment Research — November 17, 2025Get a deeper insight into the potential performance of Post Holdings (POST) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Unlocking Q3 Potential of Walmart (WMT): Exploring Wall Street Estimates for Key Metrics — Neutral
WMT Zacks Investment Research — November 17, 2025Evaluate the expected performance of Walmart (WMT) for the quarter ended October 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Why Universal Display (OLED) International Revenue Trends Deserve Your Attention — Neutral
OLED Zacks Investment Research — November 17, 2025Explore how Universal Display's (OLED) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.